# Effectiveness of the Application(APP) on Individualized Antithrombotic Therapy

Study · id `cardio:ct-nct03454854` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03454854](<https://clinicaltrials.gov/study/NCT03454854>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03454854

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 10000 participants.

## Technical summary

Registry record NCT03454854. Allocation not applicable; no masking; primary purpose treatment. Start 2017-11-01 (actual); primary completion 2019-12-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 10000 participants (planned count; ClinicalTrials.gov record NCT03454854, source copy `cardio:ctgov-nct03454854-2018-05-24`, retrieved 2026-10-26)
- Started: 2017-11-01 (actual) (ClinicalTrials.gov record NCT03454854, source copy `cardio:ctgov-nct03454854-2018-05-24`, retrieved 2026-10-26)
- Primary completion: 2019-12-30 (anticipated) (ClinicalTrials.gov record NCT03454854, source copy `cardio:ctgov-nct03454854-2018-05-24`, retrieved 2026-10-26)
- Completion: 2020-12-20 (anticipated) (ClinicalTrials.gov record NCT03454854, source copy `cardio:ctgov-nct03454854-2018-05-24`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT03454854, source copy `cardio:ctgov-nct03454854-2018-05-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03454854-2018-05-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effectiveness of the Application(APP) on Individualized Antithrombotic Therapy
- Acronym: APP
- Condition: Antithrombotic
- Intervention (Device): intelligent terminal APP
- Lead sponsor: Guangdong Provincial People's Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Guangdong Provincial People's Hospital (`cardio:org-guangdong-provincial-people-s-hospital`)

## Provenance

Content hash: dadf2c6d5021b226aded45a2f86ed98c394729d0f4a9dcd2db6b47683e0eb337
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
